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ABSTRACT
Transposons impart dynamism to the genomes they
inhabit and their movements frequently rewire the
control of nearby genes. Occasionally, their pro-
teins are domesticated when they evolve a new
function. SETMAR is a protein methylase with a
sequence-specific DNA binding domain. It began
to evolve about 50 million years ago when an Hs-
mar1 transposon integrated downstream of a SET-
domain methylase gene. Here we show that the DNA-
binding domain of the transposase targets the en-
zyme to transposon-end remnants and that this is
capable of regulating gene expression, dependent on
the methylase activity. When SETMAR was modestly
overexpressed in human cells, almost 1500 genes
changed expression by more than 2-fold (65% up-
and 35% down-regulated). These genes were en-
riched for the KEGG Pathways in Cancer and in-
clude several transcription factors important for de-
velopment and differentiation. Expression of a sim-
ilar level of a methylase-deficient SETMAR changed
the expression of many fewer genes, 77% of which
were down-regulated with no significant enrichment
of KEGG Pathways. Our data is consistent with a
model in which SETMAR is part of an anthropoid
primate-specific regulatory network centered on the
subset of genes containing a transposon end.
INTRODUCTION
Transposable elements (TEs) are almost ubiquitous and
their transposases are the most abundant genes in nature
(1). Because the genetic information encoded by TEs is usu-
ally used only for their own survival, they have been con-
sidered as selfish genomic-parasites (2). However, it is now
clear that TEs are also an important source of genetic nov-
elty (3). For example, they promote the emergence of new
gene regulatory networks by dispersing transcription factor
binding site in the genome and they give rise to new mi-
croRNAs and long intergenic non-coding RNAs (4–9). A
less frequent event is exaptation, when a TE contributes se-
quences to a new bona fide host protein and evolves a new
function (6). One of the best examples is V(D)J recombi-
nation in the vertebrate immune system (10). In this case,
the RAG1 recombinase and the recombination signal se-
quences preserve almost all of the respective functions of
the ancestral transposase and its cognate binding sites in
the transposon ends (inverted terminal repeats, ITRs). The
human CSB-PGBD3 protein, which arose from the domes-
tication of a piggyBac transposon, has been shown to af-
fect gene expression (11–13). Although it can still bind to
remnants of the ancestral transposon ends, its regulatory
activity is at least partly mediated by an interaction with
the AP-1 transcription factor. The precise functions of the
other ∼50 domesticated transposase proteins in the human
genome remain unknown (14).
The human SETMAR protein is expressed in most tis-
sues and cells and is a fusion between a SET-domain pro-
tein methylase and the Hsmar1 transposase (Figure 1A)
(15). Exaptation occurred in the anthropoid primate lin-
eage between 40 and 58 million years ago, during a period
when many key genetic changes and adaptations were tak-
ing place (16). In the region of the SETMAR gene encoding
the transposase DNA-binding domain the ratio of nonsyn-
onymous (KA) to synonymous (KS) nucleotide substitutions
is 0.1 (Figure 1A). This indicates that the domain is under
purifying selection and therefore has a function. TheKA/KS
ratio for the region encoding the transposase catalytic do-
main is 0.7, which indicates that it is drifting (16). The Hs-
mar1 transposon itself is currently inactive in humans due
to genetic drift but functional orthologs of the SET gene are
deeply conserved in the mammalian and avian lineages.
Reports have linked SETMAR to several cellular pro-
cesses including non-homologous end joining (NHEJ) (17),
integration of lentiviruses and transfected plasmids (17,18),
restart of stalled replication forks and chromosomal de-
catenation (19). Its role in these processes was attributed
to the SET domain, which was shown to methylate his-
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Figure 1. Hsmar1 remnants in the human genome and expression of ectopic SETMAR. (A) The SETMAR domain and exon structure are illustrated
together with the helix-turn-helix (HTH) DNA binding motifs and key active site residues in the methylase and transposase active sites. The third D
residue (aspartate) that coordinates the catalytic metal ion is an N (asparagine) in SETMAR. All 260 full-length copies of Hsmar1 have inactivating point
mutations and indels. Made1 elements comprise of six bp flanked by a pair of ITRs. (B and C) Distribution of the 6,334 ITRs in the human genome.
(D) A Western blot for the FLAG-tagged codon optimized SETMAR in the U2OS, SMF and SMFN cell lines. SMFN has the N210A substitution of an
essential residue in the SETMARmethylase domain active site. (E) qRT-PCR of the endogenous and the transgenic SETMAR in the SMF and SMFN cell
lines. Figures above rightmost columns are the ratios of expression derived from the RNA-seq experiments presented in Figure 3. (F) Western blot of the
indicated cell lines using an H3K36me2 antibody and a histone H3 antibody as a loading control. The lanes probed for H3 and H3K36me2, respectively,
were from a single gel loaded with the same amount of protein. The same result was obtained from three biological replicates (R1 to R3) performed on
different batches of cells.
tone H3 lysine 36 (H3K36me), and the catalytic domain of
the transposase, which was shown to cleave branched DNA
(17). On a genome-wide scale, H3K36me is one of the most
abundant epigenetic marks and has been linked with active
and inactive chromatin, transcriptional elongation and re-
pression, DNA replication and repair, alternative splicing,
dosage compensation and oncogenic transformation (20–
23). However, it should be noted that these reports include
observations in distantly related organisms that lack SET-
MAR. Thus, it is difficult to interpret the meaning of an
abundant histone mark, such as H3K36me, which depends
on its location and its respective readers, writers and erasers.
Another reason that the cellular roles of SETMAR re-
mains obscure is that there is some uncertainty regarding
its methylase and nuclease activities. Two groups presented
in vitro evidence that the nuclease activity of the trans-
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posase has been largely abolished by a substitution of the
third essential D residue in the active site and other muta-
tions (24,25). A third study failed to reproduce nucleosome
methylation in vitro but used proteomics to detect methy-
lation of the splicing factor snRNP70 by SETMAR (26).
The evolutionary conservation of theDNAbinding domain
of SETMAR rather than its catalytic domain also suggests
that the Hsmar1 ITR binding activity played an important
role in SETMAR evolution. If SETMAR was acting pri-
marily as a structure-specific DNA repair endonuclease, the
DNA binding domain might be expected to evolve neu-
trally.
In an attempt to clarify the cellular role of SETMAR, we
have tested an evolutionary conjecture that was proposed to
account for the fact that the majority of transposon exapta-
tion events in higher eukaryotes involve DNA transposons,
despite their paucity of numbers compared to the retro-
elements. The hypothesis is that the DNA-binding domain
of the transposase, which is absent in endogenous retro-
elements, is easily reused by the host (6). This hypothesis
predicts that the DNA binding domain of SETMAR serves
to target the protein to a subset of the Hsmar1 ITRs dis-
persed throughout the human genome. This is attractive be-
cause it incorporates roles for theDNAbinding domain and
its cognate binding sites in the ITRs of the ancestral trans-
poson. We have addressed the hypothesis using ChIP-exo
and RNA-seq on stable cell lines over-expressing a modest
amount of wild-type or a methyltransferase-deficient SET-
MAR. We find that SETMAR binds to ITRs located in
Hsmar1 remnants in vivo and regulates the expression of
many genes containing an ITR. Regulation is largely depen-
dent on the methyltransferase activity. These observations
suggest that the fusion of the ancestral transposase and
SET genes in anthropoid primates might have perturbed
the transcriptome significantly and could have contributed
to the emergence of new regulatory relationships between
genes.
MATERIALS AND METHODS
Plasmids
An artificial codon-optimized version of SETMAR was
synthesized by Gene Art (Thermo Fischer) and cloned into
pcDNA4TO at the EcoRI/NotI restriction sites. The signif-
icant differences between the nucleotide sequences of the en-
dogenous and exogenous SETMAR genes allowed them to
be distinguished in the RNA-seq experiments. The N210A
mutation in the methylase active site was introduced by
PCR.
Stable transfection of T-Rex-U2OS cells
For each transfection, 2.5 × 105 of cells were seeded in a
6-well plate and grown overnight in DMEM supplemented
with 10% FBS. The plasmids were transfected using Lipo-
fectamine 2000 (Invitrogen), following manufacturer’s in-
struction. After 24 h, a quarter of the cells were transferred
to 100 mm dishes and the medium supplemented with 400
g/ml of zeocin (Invivogen). After 2 weeks of selection, sin-
gle foci were picked and grown in a 24-well plate. The ex-
pression of the gene of interest was verified in each cell line
by inducing the PCMVpromoter with doxycycline at a final
concentration of 1 g/ml for 24 h.
Western blotting
Whole cell extracts were harvested from cultures at ∼90%
confluency in six-well plates. Briefly, cells were washed two
times with ice-cold PBS then pelleted for 5 min at 3000 ×
g at 4◦C. Samples were resuspended in 100 l of Radio Im-
munoPrecipitation Assay (RIPA) buffer (10 mM Tris–HCl
pH8.0, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Tri-
ton X-100, 0.1% sodium deoxycholate) with freshly added
protease inhibitor cocktail (Roche Applied Science) and in-
cubated on ice for 30minutes, with a vortexing every 10min.
Cell lysates were centrifuged for 15 min at 14 000× g at 4◦C
and the protein in the supernatants was quantified by the
Bradford assay.
Histones were harvested from cultures at ∼90% conflu-
ency in 6 cm dishes. Briefly, cells were washed two times
with ice-cold PBS and pelleted for 5 min at 3000 × g at
4◦C. Cells were resuspended in Triton Extraction Buffer
(TEB) (PBS, 0.5% Triton X-100 (v/v), 2 mM PMSF, 0.02%
NaN3 [v/v]) at a density of 107 cells/ml. Cells were lysed
for 10 min on a rotor at 4◦C, followed by centrifugation
at 400 × g for 10 minutes at 4◦C. The supernatant was re-
moved and the cells washed with half the volume of TEB,
followed by centrifugation at 400 × g for 10 min at 4◦C.
The supernatant was removed and the pellet resuspended
in 0.2 M HCl at a cell density of 4 × 107 cells per ml. The
histones were acid extracted overnight at 4◦C on a rotor.
The extract was centrifuged at 400 × g for 10 minutes at
4◦C and the supernatant recovered. Protein concentration
was determined using the Bradford assay. Protein, 2 or 20
g, was mixed with 2X SDS loading buffer, boiled for 5
minutes, and electrophoresed on a 10 or 15% SDS-PAGE
gel. Proteins were transferred to a polyvinylidene difluoride
(PVDF) membrane, which was blocked in 5% milk or BSA
(Roche) and incubated with specific primary antibodies at
4◦C overnight. After washing, membranes were incubated
with horseradish peroxidase (HRP)-conjugated secondary
antibodies for one hour at room temperature, washed, and
signals were detected with the ECL system (Promega) and
Fuji medical X-ray film (Fujifilm).
The following antibodies were used: anti-histoneH3 (rab-
bit IgG, 1:10 000 dilution, ab1791, Abcam), anti-histone
H3K36me2 (mouse IgG, 1:2000 dilution, 61019, Active
Motif), anti-beta Tubulin (rabbit polyclonal IgG, 1:500
dilution, ab6046, Abcam), anti-FLAG (rabbit, 1:500 di-
lution, F7425, Sigma). The secondary antibodies were
horseradish peroxidase-conjugated anti-mouse (goat poly-
clonal, 1:10 000 dilution, 12-349, Merck) and anti-rabbit
(goat polyclonal, 1:5000-1:10 000, ab6721, Abcam).
Transcriptomes acquisition and analysis
Total RNAswere isolated from cells grown to∼90% conflu-
ency in six-well plate with the High Pure RNA isolation kit
(Roche Applied Science), following manufacturer’s instruc-
tions. The samples were quantified with a Nanodrop Spec-
trophotometer and their quality verified with a Bioanalyzer
(Agilent). Only samples with a RIN number >9 were used.
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Illumina TrueSeq RNA Sample Preparation v2 was used
according to manufacturer’s instructions. Indexed samples
were sequenced on an Illumina NextSeq 500 machine to
generate 2 × 75 bp reads. The adapters and the low qual-
ity sequences were trimmed with Sythe and Sickle. Reads
were first filtered against rRNA and tRNA sequenced and
then mapped to the hg19 human genome assembly using
Tophat2 (27) version 2.1.0 with default options. RNA-seq
was performed on biological duplicates with a total num-
ber of mapped reads between 70 and 157 million paired
end reads. Protein-coding genes were obtained from the
ENSEMBL GRCh37.75 GTF file. For calculating the frag-
ments per kilobase of transcript per million mapped reads
(FPKM) values, exons were extracted in R with the Ge-
nomicFeatures package and grouped by ‘gene’. Expression
at the transcript level was quantified with HTSeq version
0.6.1 and differential expression was calculated with the
DESeq2 software version 3.2, keeping only the genes with
a fold change <−2 or >2 and an adjusted P-value of 0.05.
RNA-seq smear plots showing average gene expression (x-
axis) versus log2 fold change in gene expression were pro-
duced with GraphPad Prism 7.02.
qRT-PCR
U2OS cells were harvested from cultures at ∼90% conflu-
ency in six-well plates. Briefly, cells washed twice with ice-
cold PBS and pelleted for 5 min at 3000 × g at 4◦C. Cells
were resuspended in 1 ml of TRIzol (ThermoFisher Sci-
entific) and incubated at room temperature for 5 min. 200
l of chloroform was added to each lysate, vortexed for
15 s and incubated at room temperature for 3 min. The
lysates were centrifuged at 12 000 × g for 15 min at 4◦C
and the upper phase transferred to a new tube. 500 l of
isopropanol was added to each tube, mixed gently, incu-
bated at room temperature for 10 min then centrifuged at
12 000 × g for 15 min at 4◦C. After removal of the super-
natant, 1 ml of 75% ethanol was added to the pellet, vor-
texed and centrifuged at 7500 x g for 5 min at 4◦C.The pel-
lets were air-dried briefly and resuspended with 20 l of
RNase-free water. After incubating the samples for 10 min
at 55◦C, 70 l of RNase-free water, 10 l of DNase buffer
and 1 l of DNase enzyme were added to each tube and
incubated for 30 min at 37◦C. A phenol-chloroform pH4.2
extractionwas performed on each sample and theRNApel-
let resuspended in 20 l of RNase-free water. Total RNA
(500 ng) was converted to cDNA with random hexamers
and the SuperScript III kit (Invitrogen), according to the
manufacturer’s instructions. cDNAwas amplified by qPCR
with a QuantiTect SYBR Green PCR kit (QIAGEN) and
a Rotor-Gene RG-3000 (Corbett Research). For each reac-
tion, the following components were included: 1 l of tem-
plate, 1 l of primer pair mix (10 M), 3 l of water and 5
l of SYBR Green Mix (2×). The thermo-cycling parame-
ters were: 95◦C for 15 min followed by 40 cycles of 94◦C for
15 s, 57◦C for 20 s and 72◦C for 25 s. The Roto-Gene Q Se-
ries Software was used to calculate the threshold cycle (Ct)
value. Signals are presented as a percentage of Input DNA
after removal of the IgG background signal. The primers
were designed with Primer3Plus (https://primer3plus.com/
cgi-bin/dev/primer3plus.cgi) and the NCBI Primer-BLAST
tool (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to
verify the specificity of the primers. Results were repre-
sented as fold change, normalized to TUBB. The sequences
of primers used for qRT-PCR are given in Supplementary
Table S4. Experiments were replicated at least three times
to ensure reproducibility, and each RNA sample was mea-
sured in triplicate by qPCR.
ChIP-qPCR and ChIP-exo
ChIP was performed as previously described (28). Briefly,
U2OS cells were grown in 150 mm dishes until they reached
80–90% confluency (∼1 × 107 cells). The cells were then
fixed with 1% formaldehyde for 10min at room temperature
with shaking. Formaldehyde was quenched with 125 mM
glycine and incubated for 5 min at room temperature with
shaking. Cells were placed on ice and washed twice with
ice-cold PBS. Cells were scraped in ice-cold PBS and trans-
ferred to a fresh chilled Eppendorf, then centrifuged for 10
min at 1500 rpm at 4◦C. The cells were resuspended in ChIP
lysis buffer (10mMTris–HCl ph8.0, 0.25%TritonX-100, 10
mMEDTA, and protease inhibitor cocktail) and incubated
for 10 min on ice. Lysis buffer was removed by centrifuga-
tion for 5 min at 1500 × g at 4◦C and nuclear pellets were
resuspended in ChIPWash buffer (10 mMTris–HCl pH8.0,
200 mM NaCl, 1 mM EDTA, protease inhibitor cocktail).
Wash buffer was removed by centrifugation for 5 min at
1500 × g at 4◦C and nuclear pellets were resuspended in
ChIP Sonication buffer (10 mM Tris–HCl pH 8.0, 100 mM
NaCl, 1mMEDTA, protease inhibitor cocktail). Cells were
sonicated twice for 15 min at high amplitude, 30 s ON/30s
OFF on a Bioruptor (Diagenode). This was followed by
centrifugation at 13 000 rpm for 15 min at 4◦C, and the su-
pernatant was transferred to a fresh Eppendorf.
Ten microliter of Protein G Dynabeads per immunopre-
cipitation (IP) were washed with 100 l of RIPA buffer. 25
g (for histones) or 80 g (for SETMAR) of chromatin was
added and left to shake for 30 min at 4◦C. The supernatant
was recovered and the beads discarded. 1 g of antibody
(Flag M2 (F1804, Sigma), histone H3 (ab1791, Abcam),
histone H3K4me3 (ab8580, Abcam), histone H3K36me2
(60019, Active Motif), histone H3K36me3 (ab9050, Ab-
cam), RNA polymerase II (NBP2-32080, Novus Biologi-
cals), normal rabbit IgG (sc-2027, Santa Cruz Biotechnol-
ogy), normal mouse IgG (sc-2025, Santa Cruz Biotechnol-
ogy) was added and mixed overnight on a rotor at 4◦C.
15 l of Dynabeads per IP were washed in 100 l RIPA
buffer. The beads were saturated with 15 l RIPA contain-
ing 4mg/ml of bovine serum albumin (BSA) and mixed
overnight on a rotor at 4◦C.
The blocking solution was removed from the beads and
mixed with the sonicated extract incubated with antibody.
After 1-hour incubation on a rotating wheel at 4◦C, IgG su-
pernatant was retained as total input. Beads were washed
three times with 300 l ice-cold RIPA, three times with 300
l ice-coldHigh SaltWash Buffer (10mMTris–HCl pH8.0,
500 mMNaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100,
0.1% sodium deoxycholate), two times with 300 l ice-cold
LiCl Wash buffer (10 mM Tris–HCl pH8.0, 250 mM LiCl,
1 mM EDTA, 1% NP-40, 1% sodium deoxycholate) and
two times with 300 l TE (10 mM Tris–HCl pH 7.5, 1 mM
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EDTA). For each IP sample, 50 l Elution buffer (100 mM
NaHCO3, 1% SDS, 10 mM DTT) was added and mixed
for 15 min at 25◦C at 1400 rpm with shaking. The elution
was repeated once and both elutes combined. For each in-
put sample, 90 l Elution buffer (containing 10 mM DTT)
was added to 10 l total input.
RNase A (0.5 l of 10 mg/ml) was added to each sam-
ple and incubated for 30 min at 37◦C. 200 mM NaCl was
added followed by incubation for 5 h at 65◦C to reverse the
crosslinks. 2.5× volume of 100% ethanol was added and in-
cubated overnight at -20◦C. The ethanol was removed after
centrifugation for 20 minutes at 13000 rpm at 4◦C. The pel-
lets were resuspended in 100 l TE and 25 l of 5× Pro-
teinase K buffer (50 mM Tris–HCl pH 7.5, 25 mM EDTA,
1.25%SDS) and 1.5l ProteinaseK (20mg/ml) were added
to each sample. These were incubated for 2 h at 45◦C to de-
grade the proteins. DNA was purified using Qiagen PCR
Purification Kit and kept at −20◦C.
ChIP samples were analyzed by real-time qPCR with a
QuantiTect SYBRGreen PCR kit (QIAGEN) and a Rotor-
Gene RG-3000 (Corbett Research). For each reaction, the
following components were included: 1 l of template, 1 l
of primer pair mix (10M), 3l of water and 5l of SYBR
Green Mix (2×). The thermo-cycling parameters were:
95◦C for 15 min followed by 40 cycles of 94◦C for 15 s, 57◦C
for 20 s and 72◦C for 25 s. The Roto-Gene Q Series Soft-
ware was used to calculate the threshold cycle (Ct) value.
Signals are presented as a percentage of InputDNAafter re-
moval of the IgG background signal. The primers were de-
signed with Primer3Plus (https://primer3plus.com/cgi-bin/
dev/primer3plus.cgi) and the NCBI Primer-BLAST tool
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to ver-
ify the specificity of the primers. The sequences of primers
used for ChIP-qPCR are given in Supplementary Table S4.
Experiments were replicated three times and each ChIP
sample was measured in triplicate by qPCR.
ForChIP-exo experiments, approximately 15million cells
of the SMF cell line were fixed with 1% formaldehyde
for 10 min at room temperature and quenched with 0.125
M glycine for 5 min at room temperature. The cells were
washed twice with ice-cold PBS and resuspended in 0.5
ml of Cell lysis buffer (10 mM Tris pH 8.0, 10 nM NaCl,
0.5% NP40) supplemented with fresh Complete Protease
Inhibitor (CPI) cocktail (Roche Applied Science) and in-
cubated for 10 min on ice. The nuclei were pelleted for
5 min at 660 × g at 4◦C and washed once with 1 ml of
ice-cold PBS. Nuclei pellets were resuspended in 1 ml of
room temperature Nuclei Lysis Buffer (50 mM Tris pH
8.0, 10 mM EDTA, 0.32% SDS) supplemented with fresh
CPI cocktail and incubated for 10 min on ice. The nuclear
lysates were transferred to a fresh, ice-cold 15 ml Falcon
tube and the Eppendorf tube washed with 0.6 ml of cold
IP Dilution Buffer (20 mM Tris pH 8.0, 2 mM EDTA,
150 mMNaCl, 1% Triton X-100) complemented with fresh
CPI cocktail and combined with the nuclear lysates. Chro-
matin was sheared to ∼ 300 bp fragments with a Bioruptor
(Diagenode) using the following conditions: power setting:
high, time setting: 15 cycles of 30 s ‘on’/30 s ‘off’ during two
sessions of 15 min. The sonicated extracts were transferred
to fresh, ice-cold Eppendorf tubes and centrifuged for 10
min at 20 800 × g at 4◦C. The resulting sheared chromatin
and the anti-FLAG M2 (Sigma) antibody were sent to the
Peconic company (PA, USA) for further processing.
Computational analyses
Hsmar1 remnants and ITRs in the human genome. Hsmar1
remnants locations were extracted from the output of the
RepeatMasker (RM) Genomic Datasets produced for the
human genome, hg19 assembly, RM 3.3.0 track, Repbase
libraries 20120124. Hsmar1 transposon ends were obtained
using the BLAST software against the human genome, hg19
assembly, and the outputs parsed for transposon ends re-
taining at least 80% of the length and identity of the ances-
tral Hsmar1 ITR. Intragenic ITRs were obtained by inter-
secting the list of ITRs and the set of protein-coding genes
from the ENSEMBL GRCh37.75 GTF file.
ChIP-exo. The sequences were mapped against the hu-
man genome version GRCh37 (hg19) using BWA (29) ver-
sion 0.7.5a with default parameters, and BAM-formatted
files were created using Samtools (30) version 1.2. Mapped
reads were then de-duplicated using Picard to remove PCR
duplicates. The bam files from both biological replicates
were then merged and MACS (31) version 1.3.7.1 with de-
fault parameters was used for peak calling. De novo mo-
tif discovery on the peaks was performed with the MEME
suite MEME-ChIP (32) using default algorithm parame-
ters.
Nucleosome and histone methylation data. The published
datasets for H3K9ac and input reads in U2OS were ob-
tained from Encode (33) under the accession number
GSE31755. Nucleosome data for U2OS were obtained
from (34) under the accession number GSE71577. Nucle-
osome data for H1 and H9 were obtained from (35) un-
der the accession number GSE49140. Nucleosome data for
GM18508was obtained from (36) under the accession num-
ber GSE36979. Adapters were trimmed with Cutadapt v.
1.9.1 (37). All sequences weremapped usingBowtie2 v. 2.2.5
(38) against the human genome (GRCh37 hg19 from En-
sembl) with up to two mismatches allowed. Bam-formatted
files were created using SAMtools v. 1.3.1 (30) and only
uniquely mapped reads were kept. The PCR-duplicates
were removed using Picard. The total number of reads for
each sample was then normalized to a 1× depth of coverage
(nucleosomes) of the human genome or inRPKM (H3K9ac
and Input) with deepTools2 v. 2.2.4 (39). Metagene profiles
were generated using deepTools2 computeMatrix tool with
a bin size of 10 bp and the plotting data obtained with plot-
Profile –outFileNameData tool. Graphs (Input signal sub-
tracted from IP signal) were then created with GraphPad
Prism 7.02.
P-values and significance tests. P-values for hypergeomet-
ric distribution were computed with Microsoft Excel. The
hypergeometric distribution is used to determine whether a
sub-population, in this case the genes with an ITR, are over-
or under-represented in a sample, in this case the genes dif-
ferentially expressed or with a ChIP peak. Unpaired t-test
and Mann–Whitney U test were performed in GraphPad
Prism 7.02.
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RESULTS
Studies linking SETMAR to DNA recombination and re-
pair have invoked direct roles for the methylase domain
and the catalytic domain of the transposase. However, the
KA/KS profile across the gene suggest that theDNAbinding
domain of the transposase is more important than the cat-
alytic domain, which is under relaxed selection. We there-
fore set out to test the hypothesis that the primary func-
tion of SETMAR is mediated by the targeting of the pro-
tein to a subset of the 7000 Hsmar1 remnants dispersed
throughout the human genome (Figure 1A). Almost half
of the remnants are Made1 elements, which are miniature-
transposons comprised of 6 bp flanked by a pair of ITRs
(Figure 1A). About 500 of these are annotated as miR-
NAs or miRNA-like (5). Overall, within the 7000 Hsmar1
remnants we found 6334 ITRs that still have at least 80%
of the length and identity to the canonical 28 bp ITR se-
quence (Supplementary Table S1 and Methods section).
About two-thirds of these ITRs are located in non-coding
genes or the introns of protein coding genes (Figure 1B, C),
perhaps reflecting preferential integration into transcribed
regions (40,41).
Initial transient transfection experiments in osteosar-
coma cells (U2OS) with SETMAR downstream of a CMV
promoter gave an overexpression of 2500-fold. We there-
fore established stable cell lines expressing modest levels
of the protein downstream of a repressed CMV promoter.
SETMAR was FLAG-tagged (SMF) and codon optimized
so that the endogenous mRNA could be distinguished in
RNA-seq experiments. A mutant version had a single in-
activating point mutation (N210A) in the key NSHC mo-
tif of the methylase active site (SMFN) (17,42). Transgene
overexpression was in the range of 8- to 32-fold higher than
endogenous SETMAR as measured by western blotting,
RNA-seq and qRT-PCR, and did not affect the expres-
sion of the endogenous SETMAR gene (Figure 1D, E). We
also usedWestern blotting to test whether overexpression of
SMFand SMFNaffected the amount ofH3K36me2 in a hi-
stone extract (Figure 1F and Supplementary Figure S1A).
There was a significant loss in the SMFN cell extract, in-
dicating that the methylase mutant may have a dominant-
negative phenotype. However, there was only a slight in-
crease in methylation in the SMF cell extract. The absence
of a clear increase might be due to the high background of
H3K36 dimethylation in human cells, which is estimated at
30–50% of the histone H3 (43,44).
SETMAR binds Hsmar1 ITRs in vivo
To determine whether SETMAR binds Hsmar1 ITRs in
vivowe performed ChIP-exo on the SMF cell line. Amongst
the 875 ChIP peaks, the top three over-represented
sequence-motifs identified by the MEME-ChIP software
were clearly related to the canonical 28 bp Hsmar1 ITR
(Figure 2A and Supplementary Table S1). The most highly
over-represented motif corresponds with the consensus Hs-
mar1 ITR, which is bound by SETMAR in vitro (16). Bind-
ing was validated by ChIP-qPCR of intronic ITRs in four
genes in the SMFand SMFNcell lines (Supplementary Fig-
ure S1B, C). The second most over-represented motif cor-
responds to a divergent ITR present in a subset of Made1
elements (Figure 2A). The third motif is most similar to the
core transposase binding site between bp +6 to +20 of the
ITR. It also contains a similarity to the CENP-B binding
site (Figure 2A). It is worth noting that CENP-B was the
product of a much more ancient exaptation event involving
a transposon in the same superfamily as Hsmar1 (45,46).
None of the other over-represented sequence motifs identi-
fied by MEME-ChIP were related to the Hsmar1 ITR se-
quence or contained a conserved transcription factor bind-
ing site.
Overall, nearly half of the ChIP-exo peaks overlap or are
located close to an ITR or one of the two other motifs (Fig-
ure 2B). Some 34%of the peaks arewithin 500 bp of an ITR,
with 90% of these at<150 bp from the ITR (Supplementary
Figure S1D). In ameta-profile, themaximum signal is at the
center of the ITRs, which indicates direct recognition of this
sequence by SETMAR (Figure 2C). Since sequence-specific
DNA-binding proteins must compete with nucleosomes,
we integrated the ENCODE MNase-seq metaprofiles sur-
rounding ITRs to determine whether SETMAR could eas-
ily access its binding sites. We present data from our U2OS
cell line, together with a lymphoblastoid and two human
embryonic stem cell lines (Figure 2D). The profiles reveal
nucleosome depletion at the center of the ITR. This is either
the result of endogenous SETMAR binding or a property
of the sequence, which would facilitate SETMAR binding.
A phased array of nucleosome positions spreads out on ei-
ther side for ∼1 kb.
We also mapped the distribution of ChIP-exo peaks with
respect to the position of annotated genes (Figure 2E and F,
Supplementary Figure S1E, F and G). Overall, the ChIP-
exo peaks were over-represented in genic regions, presum-
ably reflecting the accessibility of genes in chromatin. Motif
1 (ITR) was the most highly over-represented, with more
than half located within 3 kb of a gene (Figure 2F).
SETMAR is mostly associated with positive regulation of
transcription
To investigate whether SETMAR regulates the expression
of genes containing an ITR located between the transcrip-
tion start site (TSS) and poly(A) site, and whether the
methytransferase activity is required for this function, we
performed RNA-seq on the SMF and SMFN cell lines, and
qRT-PCR to validate some candidates (Figure 3A, B; Sup-
plementary Figure S2A and B; Supplementary Table S2).
In SMF cells, 960 genes were up-regulated more than 2-
fold compared to the parental cell line (Figure 3A). Within
this group, genes with an ITR were significantly enriched
(117 genes, P= 1.1e-7, hypergeometric distribution). In ad-
dition, some 517 genes were down-regulated more than 2-
fold, of which 31 contained an ITR (P = 0.025, hyperge-
ometric distribution). In the SMFN cell line, the direction
of the change was reversed and the number of genes down-
regulated was three times the number up-regulated (Figure
3B). This suggests that the SETMAR methylase-mutant is
a dominant negative regulator. We also asked whether ITR-
less genes located within 10 kb of an ITR were differen-
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Figure 2. SETMAR binds Hsmar1 ITRs and other sequences in vivo. (A) SETMAR binding in vivo was assessed by ChIP-exo and enriched motifs were
identified with theMEME-ChIP software. The three most enriched motifs are presented:Motif 1 corresponds to the SETMAR binding site on the Hsmar1
ITR; Motif 2 is a degenerate ITR sequence associated with a subset of Made1 elements; Motif 3 resembles an ITR and is enriched in centromeric regions
of the genome. CENP-B box and the consensus Hsmar1 ITR are shown below. (B) Distribution of the ChIP-exo peaks with respect to annotated Hsmar1
ITRs. (C) Metaprofile of ChIP-exo reads around the center of the 419 bound ITRs. (D) MNase-seq nucleosome metaprofiles around annotate Hsmar1
ITRs were generated from the ENCODE data for U2OS, a lymphoblastoid cell line (GM18508), and two human embryonic stem cell lines (H1 and H9).
(E and F) Distribution of SETMAR ChIP-exo peaks and Motif 1 with respect to annotated protein coding genes. Peak were called with MACS2.
tially regulated by SETMAR expression. However, this was
not the case, which suggests that SETMAR does not act at
a distance (465 ITR-less genes, 11 and 17 up- and down-
regulated, respectively, in SMF).
Many of the differentially-regulated genes in the SMF
and SMFN cell lines do not contain ITRs and the changes
are likely due to secondary effects cascading through the
transcriptome. To assess the extent and direction of these
effects, we examined the overlap between the sets of up-
and down-regulated genes (Figure 3C–E). Of the 103 genes
differentially expressed >±2-fold in SMF and SMFN, 76
were changed in the opposite direction in the respective cell
lines. Furthermore, of the 960 genes up-regulated in the
SMFcells, only 7 responded in the same direction in SMFN,
which supports a requirement for SETMAR’smethylase ac-
tivity for the up-regulation of genes (Figure 3D).
SETMAR mode of action
To gain more insight into the mechanism of SETMAR,
we investigated whether SETMAR’s ITR-binding activity,
which seems to not be strongly affected by nucleosomes
(Figure 2D), is biased towards active or inactive genes. We
first considered the set of 350 intragenic ChIP peaks, de-
fined in Figure 2E, which are located in 374 genes (Figure
4A). There are more genes than ChIP peaks because of the
presence of ChIP peaks in overlapping genes. We compare
the distribution of the expression level of the genes with or
without a ChIP peak in the U2OS cell line (Supplemen-
tary Figure S2C). The main difference is that 42% of the
genes with a ChIP peak are amongst the set of most lowly
expressed genes with FPKM values between zero and one.
In contrast, only 28% of the majority of genes without a
ChIP peak are expressed in this range. This may indicate
that SETMAR has a preference for binding in genes with
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Figure 3. SETMAR regulates gene expression and is dependent on its methyltransferase activity. (A and B) Smear plots of RNA-seq data showing average
gene expression versus log2-fold change in gene expression. Fold-change and p values are color coded as indicated. The number of genes up-regulated
or down-regulated are indicated at the top and bottom of each graph, respectively. The number of genes with an ITR differentially expressed is indicated
between brackets. P-value were determined using a hypergeometric distribution. SETMAR expression is 1372 making it the 9098th most express gene out
of 16 776 genes. (C–E) Venn diagrams for the genes significantly differentially expressed more than ±2-fold from parts A and B.
a low level of expression, or that SETMAR is displaced by
transcription.
Genes with an ITR bound by SETMAR (peak <500 bp
distant) were strongly over-represented amongst the genes
with a ChIP peak (97 protein-coding and 61 non-coding
genes, P = 3.1e–78, hypergeometric distribution). There
were also 35 protein-coding and 10 non-coding genes with
a ChIP peak >500 bp from an ITR (P = 7.2e–4, hyperge-
ometric distribution) but it remains unclear whether SET-
MAR binding to these genes is linked to the presence of an
ITR.
We next considered how the genes with an ITR bound
by SETMAR responded in the SMF cell line (Figure 4B).
Out of the 97 protein-coding genes bound by SETMAR,
50 genes (52%) were differentially expressed, most of which
were up-regulated. Indeed, almost all of the genes that
changed more than 2-fold were up-regulated. In compari-
son, only 44% of the 45 genes with a ChIP peak more than
500 bp from an ITR, and only 36% of the 172 genes with
a ChIP peak but no ITR, were differentially expressed in
the SMF cell line (Supplementary Figure S2D and E). To
understand why some of the genes with a bound ITR were
not differentially expressed in the SMF cell line, we com-
pared their expression level to the average of all the others in
the parental cell line (Figure 4C). The 47 non-differentially
expressed genes with a bound ITR had the lowest aver-
age basal expression. This suggests that a gene must be ex-
pressed in the first instance to be further up-regulated by
SETMAR. Furthermore, the up-regulated genes are on av-
erage expressed at a lower level than the down-regulated
genes, and at a higher level than the non-differentially ex-
pressed genes.
To confirm that SETMAR is targeting the less-expressed
genes and not the genes expressing less stable mRNAs, we
re-analyzed the ENCODE ChIP-seq data for the parental
U2OS cell line for the presence of H3K9ac, which is asso-
ciated with active transcription (Figure 4D). The signal for
the 50 differentially regulated genes with a bound ITR had
a clear inflection close to the transcriptional start site. The
H3K9ac signal for 47 non-differentially expressed geneswas
lower and noisier.
From the RNA-seq data, we know that the methyltrans-
ferase activity is required for SETMAR’s function in gene
regulation. We therefore used ChIP-qPCR to determine
whether SETMAR increased H3K36me2 in the vicinity of
ITRs (Supplementary Figure S3A). We selected three genes
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Figure 4. Distribution of SETMAR ChiP peaks and mode of action. (A) The distribution of intragenic ChIP-exo peaks with respect to the presence of
intronic ITRs. 42% of genes have a ChIP-exo peak within 500 bp of an ITR. 12% of genes have a ChIP-exo peak >500 bp distant. 46% of genes with
a ChIP-exo peak have no intronic copies of the ITR. P-values were determined using a hypergeometric distribution. (B) The distribution of intronic
SETMAR-bound copies of the ITR with respect to non-coding and coding genes and the degree of differential expression in the SMF and SMFN cell
lines. A third of the genes have their ITR bound in the ChIP-exo experiments are significantly differentially expressed in the SMF cell line. A third of
the non-differentially expressed genes are non-coding and therefore have not been detected by the RNA-seq protocol used. DE, differentially expressed.
(C) Boxplot showing the expression level of the 97 protein coding genes with a bound ITR (ChIP-exo peak<500 bp distant) compared to the vast majority
of genes that have no ITR and no ChIP-exo peak. The rightmost three plots are subclasses of the 97 genes with a bound ITR. P-values were determined
using a Mann-Whitney U test. DE, differentially expressed; Dn., down; reg., regulated. (D) Metaprofiles for the presence of H3K9ac marked-nucleosomes
were generated for the 50 differentially expressed (DE) and 47 non-DE genes from part C using the ENCODEdata forU2OS cells. TSS, transcriptional start
site. (E) We present a model for transcriptional regulation by SETMAR. A gene is undergoing a moderate amount of transcription. An intronic ITR has
positioned nucleosomes on either side owing either to SETMARbinding or the intrinsic positioning effect of the ITR sequence itself. SETMARmethylates
nearby nucleosomes and/or RNA polymerase II associated factors such as snRNP70. Up-regulation of gene expression by SETMAR is dependent on its
methyltransferase activity and is mediated by an increase in RNA polymerase II transcription and by a possible change in mRNA stability. Blue hexagons,
methyl groups.
with intronic ITRs that are up-regulated in the SMF cell
line. In SMF cells, two of the genes had a small increase in
methylation but in the third gene it decreased.We also tested
two up-regulated genes lacking an ITR but only one had a
significant increase in H3K36me2. Thus, even though SET-
MAR methyltransferase activity is required for differential
expression, H3K36me2 is perhaps not the main driver.
Up-regulation inRNA-seq datamight be explained by an
increase in the rate of transcription and/or a higher mRNA
stability. To further investigate the mechanism of SET-
MAR, we performed RNA polymerase II (pol II) ChIP-
qPCR on LRRC55 and PBX1, which are genes with an ITR
that are up-regulated in SMF (Supplementary Figure S3B).
We detected an increase in the pol II level in the gene body
for LRRC55 and at the transcription start site (TSS) for
PBX1 in the SMF cell line compared to U2OS. We con-
firmed the pol II data for PBX1 by performing ChIP-qPCR
against H3K4me3, an active mark specific to the TSS, and
H3K36me3, an activemark in the gene body, which is added
by SETD2 in human cells and requires H3K36me2 as a sub-
strate (Supplementary Figure S3C and D). In the SMF cell
line, there was a significant increase in H3K4me3 at the TSS
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andH3K36me3 at the first ITR. Interestingly, in the SMFN
cell line there is a loss of H3K36me3 at the TSS and both
ITRs, which could be due to a lower level of its precursor
H3K36me2, the substrate for SETD2 (Supplementary Fig-
ure S3C and D).
We also examined the distribution of ITR with respect to
the TSS and the poly(A) site and to the extent and direc-
tion of differential regulation but detected no correlation
(Supplementary Figure S3E). Neither is there a significant
correlation between the number of ITRs in a gene and the
extent and direction of differential regulation (Supplemen-
tary Figure S3F).
DISCUSSION
In this studywe tested the hypothesis that theDNA-binding
domain and methylase domain of SETMAR are both im-
portant for its biological activity. We found that modest
overexpression of SETMAR causes significant changes in
the transcriptome and that the set of differentially up-
regulated genes is enriched for intronic copies of the cog-
nate ITRs (P = 1.1e–7, hypergeometric distribution). The
targeting of SETMAR to ITR sequences was confirmed by
ChIP-exo and ChIP-qPCR.
RNA-seq revealed that SETMAR expression up-
regulates about twice as many genes as it down-regulates
(Figure 3A). In contrast, SMFNexpression down-regulated
about three times as many genes as it up-regulates (Figure
3B). There was little overlap between the respective sets of
up- and down-regulated genes (Figure 3D, E), suggesting
that SETMAR acts predominantly as a positive regulator.
In the SMF cell line, we found that genes containing an ITR
were over-represented amongst the differentially expressed
genes, generally in the up-regulated group. ITR-less genes
which are nevertheless located within 10 kb of an ITR,
were under-represented amongst the set of differentially
expressed genes. This indicates that for SETMAR to affect
the expression of a gene, it must contain an ITR.
Within this set of ITR-containing differentially-regulated
genes, there was no bias in the location of the ITR with re-
spect to the TSS or the poly(A) site (Supplementary Fig-
ure S3E). Neither was there a correlation between the num-
ber of ITRs and the magnitude of the differential regula-
tion between the U2OS and SMF cell lines (Supplementary
Figure S3F). However, even though genes with an ITR are
over-represented in the set of differentially expressed genes,
most of these genes do not contain an ITR. The majority of
the changes are therefore presumably due to secondary ef-
fects. If themajority of expression level changes are indirect,
it raises the question of why the changes are overwhelm-
ingly positive? Perhaps this is explained by the fact thatmost
genes in eukaryotes are positively regulated by transcription
factors. Thus, if SETMAR up-regulates a transcription fac-
tor, such as PBX1, it is more likely to initiate a cascade of
up-regulation rather than down-regulation.
In Figure 4E, we present a tentative model for SET-
MAR’s role in genetic regulation. As an example, we illus-
trate an intronic copy of theHsmar1 ITR in a gene undergo-
ing a modest amount of transcription. SETMAR binding is
facilitated by the nucleosome free region around the ITRs
andMade1 elements (Figure 2D). Dimethylation ofH3K36
by SETMAR may open the chromatin further. It may also
recruit H3K36me2 readers, which would increase gene ex-
pression still further (not shown). Another non-exclusive
possibility is the methylation of RNA polymerase II asso-
ciated factors, such as snRNP70 (26), could regulate co-
transcriptional processes such as mRNA splicing and thus
facilitate the production of mature mRNA by decreasing
premature termination of RNA polymerase II transcrip-
tion. However, in the RNA-seq data there was no change
in the usage of exons located within 250 bp of an ITR (data
not shown). SETMARmay also methylate other chromatin
readers and/or writers to promote open chromatin around
the ITR (not shown). SETMAR’s mode of action remains
unclear but the up-regulation of gene expression appears to
be mediated directly by a higher level of transcribing RNA
polymerase II, as observed for LRRC55 and PBX1 (Sup-
plementary Figure S3B–D).
SETMAR was reported to dimethylate H3K36 in vivo in
the vicinity of DNA double strand breaks (47). However, a
different group failed to detect histone methylation by SET-
MAR in vitro (17,26). We failed to detect a significant in-
crease inH3K36me2 in the SMF cells, either in bulk or close
to bound ITRs (Figure 1F, Supplementary Figure S2C).
Perhaps the high abundance of H3K36me2 in the human
genome obscures the contribution of SETMAR. However,
we did detect a clear and consistent reduction ofH3K36me2
in the SMFN cell line (Figure 1F). In this context it is worth
considering that the methylase activity may be regulated
by the effects of co-factors, ITR binding or via an auto-
inhibitory interaction between the SET and the post-SET
domain, which might block the substrate binding pocket
(48–51).
The presence of the CENP-B binding site in the Motif
3 could indicate a targeting of SETMAR to centromeric
regions (Figure 2A). It has been shown that centromeric
regions contain both H3K4me2 and H3K36me2 marks
(52,53). However, the methyltransferases responsible are
still unknown. It is therefore tempting to hypothesize that
SETMAR could mediate the addition of H3K36me2 in
light of its ability to bind a motif containing a CENP-B
binding site.
The methylase domain of SETMAR is deeply conserved
as a free-standing protein in the mammalian and avian lin-
eages. It is pleotropic in mice and the mutants have sev-
eral abnormalities in their neurology, behavior, morphol-
ogy and metabolism (54). It is therefore interesting that the
transposase domain was exapted at a time when many of
the key genetic and adaptive changes were taking place in
the anthropoid primate lineage. For example, there are 19
genes listed under the GO term Vocalization Behavior for
humans. Of these, five have an ITR, with three of them
bound by SETMAR, and nine are differentially expressed
more than 1.5-fold in the SMF cells (Supplementary Table
S2).
In humans, SETMAR is expressed at different lev-
els in most primary tissues and cultured cells, and has
been reported to play a role in DNA recombination, re-
pair and chromosome decatenation (47,55,56). Here, we
demonstrate that SETMAR misregulation is likely to have
widespread effects on the transcriptome. However, the set
of genes differentially-expressed >2-fold in the SMF and
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SMFN cells does not include well known genome-stability
players, such as Ku, ligase IV, topoisomerases or the BRCA
genes. Rather, the differentially expressed genes aremost en-
riched for the KEGG ‘pathways in cancer’ and several GO
terms related to organ development, cell adhesion and re-
sponse to stimuli (Supplementary Table S3). This is consis-
tent with reports that SETMAR stimulates cellular prolifer-
ation and suppresses apoptosis, and that it is up-regulated in
several diseases including glioblastomas, leukemias, breast
and colon cancers (19,57–59). Misregulation of SETMAR
expression could therefore be involved in tumorigenesis by
altering gene expression, affecting how cancer cells respond
to drug treatment and promoting DNA repair through the
NHEJ.
In the present study, we focused on the exogenous ex-
pression of the Flag-tagged protein because this was needed
for ChIP-exo experiment to demonstrate a role for the
DNA binding domain. In the future, it will be interest-
ing to discover how the transcriptome responds to SET-
MAR knockdown. In this respect, it should be noted that
siRNA SETMAR-silencing in a colon cancer cell line re-
duced expression of the SOX2 transcription factor by 60%
(56). This is consistent with our RNAseq analysis in which
SOX2 was down-regulated 68% in the SMFN cell line and
up-regulated 2.7-fold in the SMF cells (Supplementary Ta-
ble S2). This is consistent with our view of SETMAR’s gen-
eral role as a positive regulator: out of the 953 genes up-
regulated ≥2-fold in the SMF cells, only 7 responded in the
same direction in the SMFN cells (Figure 3D).
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